Compare DINO & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DINO | FMS |
|---|---|---|
| Founded | 1947 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Misc Health and Biotechnology Services |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 13.6B |
| IPO Year | 2022 | 2005 |
| Metric | DINO | FMS |
|---|---|---|
| Price | $99.46 | $23.06 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 15 | 2 |
| Target Price | ★ $61.50 | $30.00 |
| AVG Volume (30 Days) | ★ 2.5M | 766.2K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.03% | 2.57% |
| EPS Growth | ★ 238.46 | N/A |
| EPS | ★ 8.48 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.01 | N/A |
| Revenue Next Year | N/A | $3.83 |
| P/E Ratio | ★ $11.44 | $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $45.71 | $20.02 |
| 52 Week High | $98.44 | $27.64 |
| Indicator | DINO | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 66.42 | 37.82 |
| Support Level | $47.04 | $22.47 |
| Resistance Level | N/A | $24.02 |
| Average True Range (ATR) | 3.44 | 0.31 |
| MACD | 0.27 | -0.09 |
| Stochastic Oscillator | 98.17 | 4.98 |
HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 350 distributors and 1,700 wholesale branded sites across 30 states. It also owns and operates 4,500 miles of petroleum product pipelines and terminals principally in the southwestern United States.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.